[Target syndromes and reaction spectra of psychopharmaceuticals. Problems in therapy and research].
Experiments were held not only to determine clinical differences in reaction for neuroleptics and antidepressants, but also to place them in relation to pharmacological data gained from animal experiments. For the tranquilizers, only a scheme of clinical impressions, could be offered since with this group of psychotropics the differences in reaction are as a rule too small to be secured statistically.
D000818:Animals; D001143:Arousal / Q000187:drug effects; D002375:Catalepsy / Q000188:drug therapy; D002415:Cats; D003863:Depression / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006212:Hallucinations / Q000188:drug therapy*; D006801:Humans; D010259:Paranoid Disorders / Q000188:drug therapy*; D011595:Psychomotor Agitation / Q000188:drug therapy*; D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy
D011619:Psychotropic Drugs
Zielsyndrome und Wirkungsspektren der Psychopharmaka. Probleme in Therapie und Forschung.